Skip to search formSkip to main contentSkip to account menu

tesmilifene

Known as: DEPMPE, DPPE, N,N-diethyl-2-(4-(phenylmethyl)phenoxy)ethanamine 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Histamine AntagonistsPhenyl EthersPlatelet Aggregation Inhibitors
cyclophosphamide/tesmilifenedoxorubicin/tesmilifene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Origin of the ligand effect in the cobalt catalyzed regioselective hydroboration of 1,3-diene.
Hydroboration of 1,3-dienes can provide useful intermediates with multiple functionalities. However, achieving high… 
2010
2010
Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P‐glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats
Objectives  It has been reported that docetaxel is a P‐glycoprotein substrate and is metabolized via the cytochrome P450 (CYP) 3A… 
2009
2009
Preferential Killing of Breast Tumor Initiating Cells by N,N-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene
Purpose:N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE; tesmilifene) is thought to potentiate the antineoplastic effect… 
2009
2009
Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene.
2008
2008
Electrophoresis of membrane-associated molecules in packed beds of bilayer-coated particles.
We describe a new method for large-scale separation of membrane-associated biomolecules using a packed bed of bilayer-coated… 
2008
2008
N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine (DPPE; tesmilifene), a chemopotentiating agent with hormetic effects on DNA synthesis in vitro, may improve survival in patients with metastatic…
N,N -diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine (DPPE; tesmilifene) is a novel anti-histaminic and chemopotentiating agent… 
2008
2008
Prostate cancer: moving forward by reinventing the wheel...but this time it is round.
The article by Attard et al in this issue of Journal of Clinical Oncology illustrates elegantly that we are gradually coming to… 
2007
2007
The phospholipidosis-lnducing potential of the chemopotentiating drug, N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene) correlates with its stimulation of phosphatidylserine…
N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene), a potent chemopotentiating drug currently in Phase III… 
2005
2005
Subgroup analysis of a phase III trial of doxorubicin vs doxorubicin plus tesmilifene in advanced breast cancer (ABC): Tesmilifene survival benefit focused on patients with more aggressive disease
756 Background: Tesmilifene (DPPE), a novel chemopotentiating small molecule, conferred a substantial (50%+) increase in median… 
2005
2005
Biological Effects of Low Level Exposures BIOMEDICAL IMPLICATIONS OF HORMESIS – PART 1 TABLE OF CONTENTS
The idea that low-dose adaptive effects as described in hormesis can be used clinically has been discussed for hundreds if not… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)